
Traws Pharma (TRAW) P/E Ratio
P/E Ratio as of Jun 13, 2025: -0.02
Average-0.0140
Median-0.0100
Minimum-0.0200
Maximum-0.0100
-0.02
Past Month-0.01 (100.00%)
The P/E ratio for Traws Pharma (TRAW) is -0.02 as of Jun 13, 2025. This represents a decrease of -50.00% compared to its 12-month average P/E ratio of -0.04. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Traws Pharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Traws Pharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Traws Pharma to industry peers.
Traws Pharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Traws Pharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Traws Pharma to industry peers.
Traws Pharma (TRAW) P/E Ratio Insights
See Traws Pharma’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Traws Pharma (TRAW)
Order type
Buy in
Order amount
Est. shares
0 shares
Traws Pharma (TRAW) P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $1.42 | -0.01 |
May 1, 2025 | $1.41 | -0.01 |
Apr 1, 2025 | $2.14 | -0.02 |
Mar 3, 2025 | $2.29 | -0.02 |
Feb 3, 2025 | $7.49 | -0.05 |
Jan 2, 2025 | $8.67 | -0.06 |
Traws Pharma (TRAW) End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.02 | -66.67% |
2024 | -0.06 | -92.21% |
2023 | -0.77 | -1.28% |
2022 | -0.78 | -69.77% |
2021 | -2.58 | -19.88% |
2020 | -3.22 | — |
FAQs About Traws Pharma (TRAW) P/E ratio
The latest P/E ratio of Traws Pharma (TRAW) is -0.02, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Traws Pharma’s last 12-month average P/E ratio is -0.04, compared to its current P/E ratio of -0.02. This reflects a decrease of -50.00%.
Traws Pharma’s current P/E ratio of -0.02 is lower than its last 12-month average P/E of -0.04. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Traws Pharma’s average P/E ratio over the last 3 years is -0.69. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Traws Pharma’s average P/E ratio over the last 5 years is -1.58. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.